Correlation Between Bank of America and Arcutis Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Bank of America and Arcutis Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Arcutis Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Arcutis Biotherapeutics, you can compare the effects of market volatilities on Bank of America and Arcutis Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Arcutis Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Arcutis Biotherapeutics.
Diversification Opportunities for Bank of America and Arcutis Biotherapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Bank and Arcutis is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Arcutis Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcutis Biotherapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Arcutis Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcutis Biotherapeutics has no effect on the direction of Bank of America i.e., Bank of America and Arcutis Biotherapeutics go up and down completely randomly.
Pair Corralation between Bank of America and Arcutis Biotherapeutics
Considering the 90-day investment horizon Bank of America is expected to generate 1.47 times less return on investment than Arcutis Biotherapeutics. But when comparing it to its historical volatility, Bank of America is 3.7 times less risky than Arcutis Biotherapeutics. It trades about 0.1 of its potential returns per unit of risk. Arcutis Biotherapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 1,001 in Arcutis Biotherapeutics on August 31, 2024 and sell it today you would earn a total of 303.00 from holding Arcutis Biotherapeutics or generate 30.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Arcutis Biotherapeutics
Performance |
| Timeline |
| Bank of America |
| Arcutis Biotherapeutics |
Bank of America and Arcutis Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Arcutis Biotherapeutics
The main advantage of trading using opposite Bank of America and Arcutis Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Arcutis Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcutis Biotherapeutics will offset losses from the drop in Arcutis Biotherapeutics' long position.| Bank of America vs. RLJ Lodging Trust | Bank of America vs. Aquagold International | Bank of America vs. Stepstone Group | Bank of America vs. Morningstar Unconstrained Allocation |
| Arcutis Biotherapeutics vs. Terns Pharmaceuticals | Arcutis Biotherapeutics vs. Amylyx Pharmaceuticals | Arcutis Biotherapeutics vs. Acumen Pharmaceuticals | Arcutis Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |